| __timestamp | BioMarin Pharmaceutical Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 31354781 |
| Thursday, January 1, 2015 | 634806000 | 43445817 |
| Friday, January 1, 2016 | 661905000 | 66489820 |
| Sunday, January 1, 2017 | 610753000 | 96886134 |
| Monday, January 1, 2018 | 696328000 | 153793000 |
| Tuesday, January 1, 2019 | 715007000 | 148369000 |
| Wednesday, January 1, 2020 | 628116000 | 151934000 |
| Friday, January 1, 2021 | 628793000 | 198532000 |
| Saturday, January 1, 2022 | 649606000 | 112128000 |
| Sunday, January 1, 2023 | 746773000 | 76192000 |
| Monday, January 1, 2024 | 747184000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, BioMarin Pharmaceutical Inc. and TG Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, BioMarin's R&D expenses have consistently outpaced those of TG Therapeutics, with BioMarin's spending peaking at approximately 750 million in 2023, a 62% increase from 2014. In contrast, TG Therapeutics saw a more volatile trajectory, with a notable peak in 2021, where their R&D expenses reached nearly 200 million, a sixfold increase from 2014. This divergence highlights BioMarin's steady commitment to innovation, while TG Therapeutics' fluctuating investments suggest a more adaptive approach. As the biotech landscape evolves, these strategic choices will likely shape their future market positions.
Research and Development Expenses Breakdown: Novartis AG vs BioMarin Pharmaceutical Inc.
R&D Insights: How Bristol-Myers Squibb Company and BioMarin Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Zoetis Inc. and BioMarin Pharmaceutical Inc.
Zoetis Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and TG Therapeutics, Inc. Allocate Funds
Research and Development Investment: Blueprint Medicines Corporation vs TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and MannKind Corporation
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.